David Domzalski
2022
In 2022, David Domzalski earned a total compensation of $1.3M as President and Chief Executive Officer at VYNE Therapeutics, a 73% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $325,156 |
|---|---|
| Option Awards | $128,044 |
| Salary | $637,560 |
| Stock Awards | $190,504 |
| Other | $12,200 |
| Total | $1,293,464 |
Domzalski received $637.6K in salary, accounting for 49% of the total pay in 2022.
Domzalski also received $325.2K in non-equity incentive plan, $128K in option awards, $190.5K in stock awards and $12.2K in other compensation.
Rankings
In 2022, David Domzalski's compensation ranked 2,536th out of 5,756 executives tracked by ExecPay. In other words, Domzalski earned more than 55.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,536 out of 5,756 | 56th |
Division Manufacturing | 1,399 out of 3,133 | 55th |
Major group Chemicals And Allied Products | 635 out of 1,419 | 55th |
Industry group Drugs | 589 out of 1,320 | 55th |
Industry Pharmaceutical Preparations | 422 out of 966 | 56th |
Source: SEC filing on November 13, 2023.
Domzalski's colleagues
We found two more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2022.
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021